Mineralys Therapeutics Inc (MLYS)
R&D Expense Growth
808.59%
Quarterly · Period ending:
MLYS R&D Expense Growth
Latest reported808.59%period ending
Latest reported808.59%period ending
MLYS Quarterly R&D Growth (QoQ) (0.00% → 808.59%)
Latest values, visible window
High-resolution chart · PNG
MLYS r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 808.5861% | |
| -0.1516% | |
| -22.4102% | |
| -17.8379% | |
| 1.0534% | |
| -15.0104% | |
| -17.4419% | |
| 37.4609% | |
| 27.7005% | |
| 29.8459% | |
| 5.2713% | |
| 89.3218% | |
| -3.3271% | |
| 57.2397% | |
| 29.0312% | |
| 8.2931% | |
| -17.4535% | |
| 2.4486% | |
| 0% |